A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.

Key facts

Study ID

NCT07481708

Run by

Merck Sharp & Dohme LLC

People needed

30

Starts

2026-03-23

Expected to finish

2026-05-25

Last updated by the study team

2026-06-02

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The key inclusion criteria include but are not limited to the following:
• Is in good health
• Has a body-mass index (BMI) between 18 and 32 kg/m\^2

You may not qualify if…

• The key exclusion criteria include but are not limited to the following:
• Has a history of clinically significant gastrointestinal disease that may impact drug absorption
• Has a history of cancer (malignancy)

Where it is running

• Celerion ( Site 0001) — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.